Effects of NSAIDs on the inner ear: Possible involvement in cochlear protection

Pharmaceuticals

Volumn 3, Issue 5, 2010, Pages 1286-1295

  Hoshino, Tomofumi ^a   Tabuchi, Keiji ^a   Hara, Akira ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cochlea; Cyclooxygenase; Lipoxygenase; NSAIDs

Indexed keywords

5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; ACETYLSALICYLIC ACID; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CAY 10404; CISPLATIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; GLUCOCORTICOID; INDOMETACIN; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; NORDIHYDROGUAIARETIC ACID; SALICYLIC ACID; UNCLASSIFIED DRUG;

ACOUSTIC STRESS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CARDIOVASCULAR DISEASE; COCHLEA INJURY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; DRUG SELECTIVITY; EAR PROTECTION; EVOKED BRAIN STEM AUDITORY RESPONSE; HEARING LOSS; HUMAN; INNER EAR DISEASE; KIDNEY DYSFUNCTION; NOISE INJURY; NONHUMAN; OTITIS MEDIA; OTOACOUSTIC EMISSION; OTOTOXICITY; OXIDATIVE STRESS; PATHOGENESIS; PERCEPTION DEAFNESS; REVIEW; RISK BENEFIT ANALYSIS; SINUSITIS; STOMACH MUCOSA INJURY; TINNITUS; TONSILLITIS;

EID: 77954937504     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph3051286     Document Type: Review

References (79)

1. Spangler, R.S. Cyclooxygenase 1 and 2 in rheumatic disease: Implications for nonsteroidal anti- inflammatory drug therapy. Semin. Arthritis. Rheum. 1996, 26, 435-446.
2. Chandrasekharan, N.V.; Dai, H.; Roos, K.L.; Evanson, N.K.; Tomsik, J.; Elton, T.S.; Simmons, D.L. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. Proc. Natl. Acad. Sci. USA. 2002, 99, 13926-13931.
3. Barnett, J.; Chow, J.; Ives, D.; Chiou, M.; Mackenzie, R.; Osen, E.; Nguyen, B.; Tsing, S.; Bach, C.; Freire, J.; Chan, H.; Sigal, E.; Ramesha, C. Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. Biochim. Biophys. Acta 1994, 1209, 130-139.
4. Blanco, F.J.; Guitian, R.; Moreno, J.; de Toro, F.J.; Galdo, F. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes. J. Rheumatol. 1999, 26, 1366-1373.
5. Stanfield, K.M.; Bell, R.R.; Lisowski, A.R.; English, M.L.; Saldeen, S.S.; Khan, K.N. Expression of cyclooxygenase-2 in embryonic and fetal tissues during organogenesis and late pregnancy. Birth Defects Res. A 2003, 67, 54-58.
6. Burdan, F. Comparison of developmental toxicity of selective and non-selective cyclooxygenase- 2 inhibitors in CRL: (WI)WUBR Wistar rats-DFU and piroxicam study. Toxicology 2005, 211, 12-25.
7. Capdevila, J.H.; Harris, R.C.; Falck, J.R. Microsomal cytochrome P450 and eicosanoid metabolism. Cell. Mol. Life Sci. 2002, 59, 780-789.
8. Boettcher, F.A.; Salvi, R.J. Salicylate ototoxicity: review and synthesis. Am. J. Otolaryngol. 1991, 12, 33-47.
9. Brien, J.A. Ototoxicity associated with salicylates: A brief review. Drug Saf. 1993, 9, 143-148.
10. Cazals, Y. Auditory sensori-neural alterations induced by salicylate. Prog. Neurobiol. 2000, 62, 583-631.
11. Kujawa, S.G.; Fallon, M.; Bobbin, R.P. Intracochlear salicylate reduces low-intensity acoustic and cochlear microphonic distortion products. Hear. Res. 1992, 64, 73-80.
12. Ueda, H.; Yamamoto, Y.; Yanagita, N. Effct of aspirin on transiently evoked otoacoustic emissions in guinea pigs. ORL J. Otorhinolaryngol. Relat. Spec. 1996, 58, 61-67.
13. Gold, A.; Wilpizeski, C.R. Studies in auditory adaptation: II. Some effects of sodium salicylate on evoked auditory potentials in cats. Laryngoscope 1966, 76, 674-685.
14. Woodford, C.M.; Henderson, D.; Hamernik, R.P. Effects of combinations of sodium salicylate and noise on the auditory threshold. Ann. Otol. Rhinol. Laryngol. 1978, 87, 117-127.
15. Tabuchi, K.; Tsuji, S.; Hara, A.; Kusakari, J. Effect of calmodulin antagonists on the compound action potential of the cochlea. Hear. Res. 2000, 145, 59-64.
16. Mammano, F.; Ashmore, J.F. Reverse transduction measured in the isolated cochlea by laser Michelson interferometry. Nature 1993, 365, 838-841.
17. Murugasu, E.; Russell, I.J. Salicylate ototoxicity: The effects on basilar membrane displacement, cochlear microphonics and neural responses in the basal turn of the guinea pig cochlea. Auditory Neurosci. 1995, 1, 139-150.
18. Puel, J.L.; Bobbin, R.P.; Fallon, M. Salicylate, mefenamate, meclofenamate, and quinine on cochlear potentials. Otolaryngol. Head Neck Surg. 1990, 102, 66-73.
19. Didier, A.; Miller, J.M.; Nuttall, A.L. The vascular component of sodium salicylate ototoxicity in the guinea pig. Hear. Res. 1993, 69, 199-206.
20. Dieler, R.; Shehata-Dieler, W.E.; Richter, C.P.; Klinke, R. Effects of endolymphatic and perilymphatic application of salicylate in the pigeon. II: Fine structure of auditory hair cells. Hear. Res. 1994, 74, 85-98.
21. Douek, E.E.; Dodson, H.C.; Bannister, L.H. The effects of sodium salicylate on the cochlea of guinea pigs. J. Laryngol. Otol. 1983, 97, 793-799.
22. Johnsen, N.J.; Elberling, C. Evoked acoustic emissions from the human ear. I. Equipment and response parameters. Scand. Audiol. 1982, 11, 3-12.
23. Janssen, T.; Boege, P.; Oestreicher, E.; Arnold, W. Tinnitus and 2f1-f2 distortion product otoacoustic emissions following salicylate overdose. J. Acoust. Soc. Am. 2000, 107, 1790-1792.
24. Wu, T.; Lv, P.; Yamoah, E.N.; Nuttall, A.L. Effect of Salicylate on KCNQ4 of the Guinea Pig Outer Hair Cell. J. Neurophysiol. 2010, [Epub ahead of print].
25. Wei, L.; Ding, D.; Salvi, R. Salicylate-induced degeneration of cochlea spiral ganglion neurons- apoptosis signaling. Neuroscience 2010, [Epub ahead of print].
26. Chen, G.D.; Kermany, M.H.; D'Elia, A.; Ralli, M.; Tanaka, C.; Bielefeld, E.C.; Ding, D.; Henderson, D.; Salvi, R. Too much of a good thing: Long-term treatment with salicylate strengthens outer hair cell function but impairs auditory neural activity. Hear. Res. 2010, [Epub ahead of print].
27. Miller, B.; Sarantis, M.; Traynelis, S.F.; Attwell, D. Potentiation of NMDA receptor currents by arachidonic acid. Nature 1992, 355, 722-725.
28. Niedzielski, A.S.; Wenthold, R.J. Expression of AMPA, kainate, and NMDA receptor subunits in cochlear and vestibular ganglia. J. Neurosci. 1995, 15, 2338-2353.
29. Ruel, J.; Chen, C.; Pujol, R.; Bobbin, R.P.; Puel, J.L. AMPA-preferring glutamate receptors in cochlear physiology of adult guinea pig. J. Physiol. 1999, 518, 667-680.
30. Ruel, J.; Bobbin, R.P.; Vidal, D.; Pujol, R.; Puel, J.L. The selective AMPA receptor antagonist GYKI 53784 blocks action potential generation and excitotoxicity in the guinea pig cochlea. Neuropharmacology 2000, 39, 1959-1973.
31. Guitton, M.J.; Caston, J.; Ruel, J.; Johnson, R.M.; Pujol, R.; Puel, J.L. Salicylate induces tinnitus through activation of cochlear NMDA receptors. J. Neurosci. 2003, 23, 3944-3952.
32. Knipper, M.; Zimmermann, U.; Muller, M. Molecular aspects of tinnitus. Hear. Res. 2009, [doi:10.1016/j.heares.2009.07.013].
33. Sun, W.; Lu, J.; Stolzberg, D.; Gray, L.; Deng, A.; Lobarinas, E.; Salvi, R.J. Salicylate increases the gain of the central auditory system. Neuroscience 2009, 159, 325-334.
34. Norena, A.J.; Moffat, G.; Blanc, J.L.; Pezard, L.; Cazals, Y. Neural changes in the auditory cortex of awake guinea pigs after two tinnitus inducers: Salicylate and acoustic trauma. Neuroscience 2010, 166, 1194-1209.
35. Eggermont, J.J. Role of auditory cortex in noise- and drug-induced tinnitus. Am. J. Audiol. 2008, 17, S162-S169.
36. Kizawa, K.; Kitahara, T.; Horii, A.; Maekawa, C.; Kuramasu, T.; Kawashima, T.; Nishiike, S.; Doi, K.; Inohara, H. Behavioral assessment and identification of a molecular marker in a salicylate-induced tinnitus in rats. Neuroscience 2010, 165, 1323-1332.
37. Yu, N.; Zhu, M.-L.; Johnson, B.; Liu, Y.-P.; Jones, R.O.; Zhao, H.-B. Prestin up-regulation in chronic salicylate (aspirin) administration: An implication of functional dependence of prestin expression. Cell Mol. Life Sci. 2008, 65, 2407-2418.
38. Panford-Walsh, R.; Singer, W.; Ruttiger, L.; Hadjab, S.; Tan, J.; Geisler, H.S.; Zimmermann, U.; Kopschall, I.; Rohbock, K.; Vieljans, A.; Oestreicher, E.; Knipper, M. Midazolam reverses salicylate-induced changes in brain-derived neurotrophic factor and arg3.1 expression: implications for tinnitus perception and auditory plasticity. Mol. Pharmacol. 2008, 74, 595-604.
39. Singer, W.; Panford-Walsh, R.; Watermann, D.; Hendrich, O.; Zimmermann, U.; Kopschall, I.; Rohbock, K.; Knipper, M. Salicylate alters the expression of calcium response transcription factor 1 in the cochlea: implications for brain-derived neurotrophic factor transcriptional regulation. Mol. Pharmacol. 2008, 73, 1085-1091.
40. Nam, B.H.; Kim, P.S.; Park, Y.S.; Worrell, L.A.; Park, S.K.; John, E.O.; Jung, T.T.; Duncan, J.; Fletcher, W.H. Effect of corticosteroid on salicylate-induced morphological changes of isolated cochlear outer hair cells. Ann. Otol. Rhinol. Laryngol. 2004, 113, 734-737.
41. Zhi, M.; Ratnanather, J.T.; Ceyhan, E.; Popel, A.S.; Brownell, W.E. Hypotonic swelling of salicylate-treated cochlear outer hair cells. Hear. Res. 2007, 228, 95-104.
42. Zheng, J.; Shen, W.; He, D.Z.; Long, K.B.; Madison, L.D.; Dallos, P. Prestin is the motor protein of cochlear outer hair cells. Nature 2000, 405, 149-155.
43. Yang, K.; Huang, Z.W.; Liu, Z.Q.; Xiao, B.K.; Peng, J.H. Long-term administration of salicylate enhances prestin expression in rat cochlea. Int. J. Audiol. 2009, 48, 18-23.
44. Lamm, K.; Arnold, W. The effect of predonisolone and non-steroidal anti-inflammatory agents on the normal and noise-damaged guinea pig inner ear. Hear. Res. 1998, 115, 149-161.
45. Kopke, R.D.; Weisskopf, P.A.; Boone, J.L.; Jackson, R.L.; Wester, D.C.; Hoffer, M.E.; Lambert, D.C.; Charon, C.C.; Ding, D.L.; McBride, D. Reduction of noise-induced hearing loss using L- NAC and salicylate in the chinchilla. Hear. Res. 2000, 149, 138-146.
46. Sha, S.H.; Schacht, J. Salicylate attenuates gentamicin-induced ototoxicity. Lab. Invest. 1999, 79, 807-813.
47. Li, G.; Sha, S.H.; Zotova, E.; Arezzo, J.; Van de Water, T.; Schacht, J. Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action. Lab. Invest. 2002, 82, 585-596.
48. Hyppolito, M.A.; de Oliveira, J.A.; Rossato, M. Cisplatin ototoxicity and otoprotection with sodium salicylate. Eur. Arch. Otorhinolaryngol. 2006, 263, 798-803.
49. Yamashita, D.; Jiang, H.Y.; Le Prell, C.G.; Schacht, J.; Miller, J.M. Post-exposure treatment attenuates noise-induced hearing loss. Neuroscience 2005, 134, 633-642.
50. Stjernschantz, J.; Wentzel, P.; Rask-Andersen, H. Localization of prostanoid receptors and cyclooxygenase enzymes in guinea pig and human cochlea. Hear. Res. 2004, 197, 65-73.
51. Ziegler, E.A.; Brieger, J.; Heinrich, U.R.; Mann, W.J. Immunohistochemical localization of cyclooxygenase isoforms in the organ of Corti and the spiral ganglion cells of guinea pig cochlea. ORL J. Otorhinolaryngol. Relat. Spec. 2004, 66, 297-301.
52. Heinrich, U.R.; Bringer, J.; Selivanova, O; Feltens, R.; Eimermacher, A.; Schäfer, D.; Mann, W.J. COX-2 expression in the guinea pig cochlea is partly altered by moderate sound exposure. Neurosci. Lett, 2006, 39, 121-126.
53. Previati, M.; Lanzoni, I.; Corbacella, E.; Magosso, S.; Giuffrè, S.; Francioso, F.; Arcelli, D.; Volinia, S.; Barbieri, A.; Hatzopoulos, S.; Capitani, S.; Martini, A. RNA expression induced by cisplatin in an organ of Corti-derived immortalized cell line. Hear. Res. 2004, 196, 8-18.
54. Hoshino, T.; Tabuchi, K.; Hirose, Y.; Uemaetomari, I.; Murashita, H.; Tobita, T.; Hara, A. The non-steroidal anti-inflammatory drugs protect mouse cochlea against acoustic injury. Tohoku J. Exp. Med. 2008, 216, 53-59.
55. Tabuchi, K.; Ito, Z.; Tsuji, S.; Wada, T.; Takahashi, K.; Hara, A.; Kusakari, J. The contribution of phospholipase A2 to the cochlear dysfunction induced by transient ischemia. Hear. Res. 2000, 144, 1-7.
56. Hirose, Y.; Tabuchi, K.; Oikawa, K.; Murashita, H.; Sakai, S.; Hara, A. The effects of the glucocorticoid receptor antagonist RU486 and phospholipase A2 inhibitor quinacrine on acoustic injury of the mouse cochlea. Neurosci. Lett. 2007, 413, 63-67.
57. Tabuchi, K.; Oikawa, K.; Uemaetomari, I.; Tsuji, S.; Wada, T.; Hara, A. Glucocorticoids and dehydroepiandrosterone sulfate ameliorate ischemia-induced injury of the cochlea. Hear. Res. 2003, 180, 51-56.
58. Tabuchi, K.; Murashita, H.; Tobita, T.; Oikawa, K.; Tsuji, S.; Uemaetomari, I.; Hara, A. Dehydroepiandrosterone sulfate reduces acoustic injury of the guinea-pig cochlea. J. Pharmacol. Sci. 2005, 99, 191-194.
59. Gewert, K.; Sundler, R. Dexamethasone down-regulates the 85 kDa phospholipase A2 in mouse macrophages and suppresses its activation. Biochem. J. 1995, 307, 499-504.
60. Brune, K. Safety of anti-inflammatory treatment--new ways of thinking. Rheumatology (Oxford) 2004, 43(Suppl. 1), i16-i20.
61. Jung, T.T.; Park, Y.M.; Miller, S.K.; Rozehnal, S.; Woo, H.Y.; Baer, W. Effect of exogenous arachidonic acid metabolites applied on round window membrane on hearing and their levels in the perilymph. Acta Oto-laryngol. 1992, 493, 171-176.
62. Umemura, K.; Asai, Y.; Uematsu, T.; Nakashima, M. Role of thromboxane A2 in a microcirculation disorder of the rat inner ear. Eur. Arch. Otorhinolaryngol. 1993, 250, 342-344.
63. Clerici, W.J.; Hensley, K.; DiMartino, D.L.; Butterfield, D.A. Direct detection of ototoxicant- induced reactive oxygen species generation in cochlear explants. Hear. Res. 1996, 98, 116-124.
64. Choung, Y.H.; Taura, A.; Pak, K.; Choi, S.J.; Masuda, M.; Ryan, A.F. Generation of highly- reactive oxygen species is closely related to hair cell damage in rat organ of Corti treated with gentamicin. Neuroscience 2009, 161, 214-226.
65. Yamane, H.; Nakai, Y.; Takayama, M.; Konishi, K.; Iguchi, H.; Nakagawa, T.; Shibata, S.; Kato, A.; Sunami, K.; Kawakatsu, C. The emergence of free radicals after acoustic trauma and strial blood flow. Acta Oto-laryngol. 1995, 519, 87-92.
66. Yamasoba, T.; Nuttall, A.L.; Harris, C.; Raphael, Y.; Miller, J.M. Role of gluthathione in protection against noise-induced hearing loss. Brain Res. 1998, 784, 82-90.
67. Ohlemiller, K.K.; Wright, J.S.; Dugan, L.L. Early elevation of cochlear reactive oxygen species following noise exposure. Audiol. Neurootol. 1999a, 4, 229-236.
68. Murashita, H.; Tabuchi, K.; Hoshino, T.; Tsuji, S.; Hara, A. The effects of tempol, 3- aminobenzamide and nitric oxide synthase inhibitors on acoustic injury of the mouse cochlea. Hear. Res. 2006, 214, 1-6.
69. Ohlemiller, K.K.; Dugan, L.L. Elevation of reactive oxygen species following ischemia- reperfusion in mouse cochlea observed in vivo. Audiol. Neurootol. 1999, 4, 219-228.
70. Tabuchi, K.; Ito, Z.; Wada T.; Hara A.; Kusakari, J. The effect of mannitol upon cochlear dysfunction induced by transient local anoxia. Hear. Res. 1998, 126, 28-36.
71. Tabuchi, K.; Tsuji, S.; Fujihira, K.; Oikawa, K.; Hara, A.; Kusakari, J. Outer hair cells functionally and structurally deteriorate during reperfusion. Hear. Res. 2002, 173, 153-163.
72. Staecker, H.; Zheng, Q.Y.; Van DeWater T.R. Oxidative stress in aging in the C57B16/J mouse cochlea. Acta Oto-laryngol. 2001, 121, 666-672.
73. Dinis, T.C.; Maderia, V.M.; Almeida, L.M. Action of phenolic derivatives (acetaminophen, salicylate, and 5-aminosalicylate) as inhibitors of membrane lipid peroxidation and as peroxyl radical scavengers. Arch. Biochem. Biophys. 1994, 315, 161-169.
74. Yu, W.K.; Wells, P.G. Evidence for lipoxygenase-catalyzed bioactivation of phenytoin to a teratogenic reactive intermediate: in vivo studies using linoleic acid-dependent soybean lipoxygenase, and in vivo studies using pregnant CD-1 mice. Toxicol. Appl. Pharmacol. 1995, 131, 1-12.
75. Chernov, M.V.; Stark, G. R. The p53 activation and apoptosis induced by DNA damage are reversibly inhibited by salicylate. Oncogene 1997, 14, 2503-2510.
76. Yin, M.J.; Yamamoto, Y.; Gaynor, R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 1998, 396, 77-80.
77. Masuda, M.; Nagashima, R.; Kanzaki, S.; Fujioka, M.; Ogita, K.; Ogawa, K. Nuclear factor-kappa B nuclear translocation in the cochlea of mice following acoustic overstimulation. Brain Res. 2006, 1068, 237-247.
78. Maldonado, V.; Melendez-Zajgla, J.; Ortega, A. Modulation of NF-kappa B, and Bcl-2 in apoptosis induced by cisplatin in HeLa cells. Mutat. Res. 1997, 381, 67-75.
79. Jiang, H.; Sha, S.H.; Schacht, J. NF-kappaB pathway protects cochlear hair cells from aminoglycoside-induced ototoxicity. J. Neurosci. Res. 2005, 79, 644-651.